Shu Zhang

3PUBLICATIONS
8CO-AUTHORS
Cancer cell biologyMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 08, 2026
Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma.

|Jul 23, 2025
Exploring the Molecular Mechanism of 1,25(OH)2D3 Reversal of Sorafenib Resistance in Hepatocellular Carcinoma Based on Network Pharmacology and Experimental Validation.

Zhiyan Long, Xiangyi Wu, Tianxin Luo

|May 06, 2023
Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification.

Ye Yang, Jiaoyan Yan, Jian Huang

Pageof 1

Frequent Collaborators

3 joint publications

Jian Huang

1 joint publications

Ye Yang

1 joint publications

Jiaoyan Yan

1 joint publications

Xiangyi Wu